NCT05504291

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2022-11-04Est. Completion: 2028-03-31

Enrollment target: 26 participants

Locations

Children's Hospital of Alabama, Birmingham, Alabama, United States
Children's Hospital Los Angeles, Los Angeles, California, United States
Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
C S Mott Children's Hospital, Ann Arbor, Michigan, United States
Washington University School of Medicine, St Louis, Missouri, United States
Duke University Medical Center, Durham, North Carolina, United States
Children's Hospital Medical Center of Akron, Akron, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Dell Children's Medical Center of Central Texas, Austin, Texas, United States
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States

Retinoblastoma

The primary objective of this protocol is to evaluate the response rate of bilateral disease participants who have at le…

Memphis, United StatesEst. completion Mar 17, 2023

RetinoblastomaRetinoblastoma BilateralRetinoblastoma Unilateral

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB…

Phoenix, United StatesEst. completion Dec 31, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.